Clin2
NCT07409922Likely a fitRecruiting

Testing KR23343 in healthy volunteers

Healthy

This study tests a new medicine, KR23343, in healthy adults to see how the body handles it at different doses. It helps find the right dose and check for any early side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
92 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are between 18 and 45 years old.
  • You are in good general health and not taking any regular medications.
  • You have a body mass index (BMI) between 19 and 28.
  • You are willing to use effective birth control during the study and for 3 months after.
  • You have not donated a lot of blood (400 mL or more) in the last 3 months.
  • You do not smoke more than 10 cigarettes a day and can stop smoking during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06549309Recruiting· Phase 1
Early safety study of JMKX003801 in healthy adults

This early-stage study tests whether a new oral drug (JMKX003801) is safe in healthy volunteers. It helps find the right dose and checks for side effects.

Shanghai, Shanghai Municipality
NCT07501039Recruiting· Phase 1
First test of BLKR201 in healthy adults

This study tests a new medicine, called BLKR201, for the first time in people. It is given to healthy volunteers to see how safe it is and how the body handles it.

Lincoln, Nebraska
NCT07678463Recruiting· Phase 1
Testing a new medicine in healthy volunteers

This study tests a new experimental medication (QX-4533) in healthy volunteers to find the best dose and see how it works in the body. It involves taking the medication and having your health monitored closely over time.

Brisbane, Queensland
NCT06745297Recruiting· Phase 1
Testing a new medicine in healthy men for safety

This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.

Berlin
NCT06577337Recruiting· Phase 1
Testing a new drug (M5542) in healthy volunteers

This early-phase study tests a new experimental drug (M5542) in healthy volunteers to see how safe it is and how the body processes a single dose. If you are in good health and meet simple weight and medical history criteria, you may be able to join.

Neu-Ulm
NCT07743151Not yet recruiting· Phase 1
Testing a new medicine in healthy people

This trial tests a new medicine called MK-1406 in healthy volunteers to make sure it's safe before it can be studied in patients. If you're generally healthy, you could help advance medical research.

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.